A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)

Clinical trial NCT06747949 · RECRUITING

Trial details

NCT number: NCT06747949
Sponsor: Amgen
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Sjögren's Syndrome

Start date: 2025-02-25
Primary completion: 2029-12-11
Enrollment: 844

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.